Olema Pharmaceuticals, Inc. OLMA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$53.09M-15.3% | -$46.06M-9.1% | -$42.22M+3.6% | -$43.78M-44.1% | -$30.39M+9.5% | ||
| $119K-36.4% | $187K+335% | $43K-67.4% | $132K+3.1% | $128K+10.3% | ||
| $10.15M+138% | $4.27M+0.4% | $4.25M-9.4% | $4.69M+7.2% | $4.38M-30.8% | ||
| -$5.68M-198% | $5.77M— | —— | —— | -$4.31M-271% | ||
| -$2.6M-158% | $4.46M— | $0-100% | $1.86M+438% | -$549K-129% | ||
| $1.3M-64.1% | $3.63M-38.5% | $5.9M-53.5% | $12.7M+213% | -$11.25M-604% | ||
| $301K0.0% | $301K+0.3% | $300K+4.2% | $288K+0.3% | $287K0.0% | ||
| -$313K0.0% | -$313K-0.6% | -$311K0.0% | -$311K-0.6% | -$309K-1.3% | ||
| —— | -$1.57M0.0% | -$1.57M0.0% | -$1.57M0.0% | -$1.57M+23.0% | ||
| -$45.99M-20.0% | -$38.33M-11.0% | -$34.53M-15.5% | -$29.88M+32.1% | -$43.98M-67.3% | ||
| $4.53M+103% | -$162.18M-1,039% | $17.27M— | —— | -$45.08M+60.6% | ||
| $8.43M+7.0% | $7.88M+19,120% | $41K-82.5% | $234K-0.8% | $236K-60.0% | ||
| $4.41M— | —— | —— | —— | —— | ||
| $45.7M-78.6% | $213.55M+520,759% | $41K+102% | -$2.52M-1,234% | $222K-99.9% | ||
| $4.25M— | —— | -$17.21M— | —— | -$88.84M-186% | ||
| —— | -$1.57M0.0% | -$1.57M0.0% | -$1.57M0.0% | -$1.57M+23.0% | ||
| -$313K0.0% | -$313K-0.6% | -$311K0.0% | -$311K-0.6% | -$309K-1.3% | ||
| $1.3M-64.1% | $3.63M-38.5% | $5.9M-53.5% | $12.7M+213% | -$11.25M-604% | ||
| $100K-79.8% | $496K-87.3% | $3.91M+406% | $773K-19.9% | $965K+162% | ||
| -$2.6M-158% | $4.46M— | $0-100% | $1.86M+438% | -$549K-129% | ||
| $1.27M— | —— | $1.32M-22.9% | $1.71M-18.5% | $2.1M+29.1% | ||
| $301K0.0% | $301K+0.3% | $300K+4.2% | $288K+0.3% | $287K0.0% | ||
| —— | —— | —— | —— | $14K— | ||
| $237K— | —— | —— | —— | —— | ||
| $41.92M— | —— | $0— | —— | —— | ||
| —— | $51.35M0.0% | $51.35M0.0% | $51.35M0.0% | $51.35M— | ||
| -$313K0.0% | -$313K-0.6% | -$311K0.0% | -$311K-0.6% | -$309K-1.3% | ||
| —— | -$23.75K0.0% | -$23.75K0.0% | -$23.75K0.0% | -$23.75K+71.8% | ||
| —— | $44.25K0.0% | $44.25K0.0% | $44.25K0.0% | $44.25K-76.3% | ||
| —— | $144.5K0.0% | $144.5K0.0% | $144.5K0.0% | $144.5K-91.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Olema Pharmaceuticals, Inc. generate?
- Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.
- Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.